Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: GREG FINLEY who wrote (430)	1/15/2000 11:49:00 PM
From: geewiz	Read Replies (1) \| Respond to of 534

Greg, check out this interesting conference comming up in April; nfid.org ask your inside contacts if Jim is covering it! It would be a disappointment to miss such an opportunity! later, art

To: GREG FINLEY who wrote (430)	1/18/2000 10:51:00 AM
From: geewiz	Respond to of 534

Hello Greg, My enthusiasm for our platform has become more clearly focused on two product markets; Bioject as an enabling technology and optimized delivery company for use in oncology and cardiovascular fields - the therapeutic approach. Bioject as an enabling delivery and custom package company for massive inoculations of stable DNA vaccinations - the preventative approach. I bought my first shares in 94' with confidence that our products would gain ready market acceptance in the campaign to curb needle stick injuries. That was a gross miscalculation. Many of the posts over on YAHOO still hold on to this hope; I think that it may contribute to our product acceptance but there are far greater reasons to have confidence in our market dominance; although I realize this does require connecting some dots and making some conclusions of one's own! The greatest underlying assumption is that the jet injection will prove to have greater vector uptake by targeted biomass (muscle or organ) and given Powderjects' success and our own published results that is no longer a leap of faith! And the most hopeful part of this is institutional holding at a small percent of our outstanding shares. later, art

To: GREG FINLEY who wrote (430)	1/23/2000 10:23:00 AM
From: geewiz	Read Replies (2) \| Respond to of 534

Greg, Thanks for your thoughtful comments, I have no objections to your using or linking my posts. I once had faith that depth of analysis and research would get respect on the YAHOO boards but I've had sobering experiences to the contrary, and I seldom post there. URGENT ALERT; I noticed the volume in VICL was ten times average on Friday. Most of this was early in the day before the day traders started buying thousand share lots. There was evidently an after market CC with Robbie Stephens??? Do you know anything? Evidently the subject was a genomics link for naked DNA vaccines. BJCT was not mentioned, but I bet it will use our platform.....I'm still checking, here's the link to the YAHOO VICL board.... messages.yahoo.com later, art